Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sicong Li, Xuting Li, Dingsheng Yuan, Bin Wang, Rui Yang, Min Zhang, Jinliang Li & Fuqiang Zeng. (2021) Effects of paeoniflorin on the activities and mRNA expression of rat CYP1A2, CYP2C11 and CYP3A1 enzymes in vivo. Xenobiotica 51:9, pages 961-967.
Read now
Read now
Keiichi Morita, Motohiro Kato, Toshiyuki Kudo & Kiyomi Ito. (2020) In vitro–in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization. Xenobiotica 50:9, pages 1064-1075.
Read now
Read now
Ravindra V. Alluri, Rui Li & Manthena V. S. Varma. (2020) Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 387-401.
Read now
Read now
Maki Miyamoto, Shinji Iwasaki, Ikumi Chisaki, Sayaka Nakagawa, Nobuyuki Amano & Hideki Hirabayashi. (2017) Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver. Xenobiotica 47:12, pages 1052-1063.
Read now
Read now
Zuzana E. Haarhoff, Melissa A. Kramer, Tatyana A. Zvyaga, Jun Zhang, Priyadeep Bhutani, Murali Subramanian & A. David Rodrigues. (2017) Comprehensive evaluation of liver microsomal cytochrome P450 3A (CYP3A) inhibition: comparison of cynomolgus monkey and human. Xenobiotica 47:6, pages 470-478.
Read now
Read now
Yohei Kosugi & Junzo Takahashi. (2015) Species differences and substrate specificity of CYP3A heteroactivation by efavirenz. Xenobiotica 45:4, pages 345-352.
Read now
Read now
Mario Pellegatti. (2013) Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing. Expert Opinion on Drug Metabolism & Toxicology 9:9, pages 1171-1180.
Read now
Read now
Articles from other publishers (4)
Nai-Rong Liu, Kai Yang, Wen-Ting Li, Zhi-Hua Pang, Qing Zhang, Jia-Jia Wang, Wen-Xi Dang, Ruo-Yong Jia, Zhi-Wei Fu, Yi-Xuan Li, Zhu-Hua Yao & Zhong-Ze Fang. (2020) Evaluation of the inhibition of chlorophenols towards human cytochrome P450 3A4 and differences among various species. Science of The Total Environment 724, pages 138187.
Crossref
Crossref
Takuya Ebihara, Mitsuhiro Nishihara, Junzo Takahashi, Fumihiro Jinno & Yoshihiko Tagawa. (2018) Differences in nonclinical pharmacokinetics between species and prediction of human pharmacokinetics of TAK-272 (SCO-272), a novel orally active renin inhibitor. Biopharmaceutics & Drug Disposition 39:3, pages 175-183.
Crossref
Crossref
Kenta Haraya, Motohiro Kato, Koji Chiba & Yuichi Sugiyama. (2016) Prediction of inter-individual variability on the pharmacokinetics of CYP1A2 substrates in non-smoking healthy volunteers. Drug Metabolism and Pharmacokinetics 31:4, pages 276-284.
Crossref
Crossref
Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai & Hideyuki Yamada. (2014) A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes. Drug Metabolism and Disposition 42:9, pages 1540-1547.
Crossref
Crossref